Full-Time
Posted on 8/26/2025
Biomarker data platform for drug development
$62.5k - $93.7k/yr
Remote in USA
Remote
Quartz Bio provides an AI-powered precision medicine platform that operates as a SaaS for drug development teams. It offers a fully connected data ecosystem that links clinical, sample, and biomarker data, enabling autonomous data ingestion and conversational insights to streamline biomarker discovery and validation. Unlike generic analytics tools, its Precision Medicine AI Agent Platform integrates diverse data types across the drug development lifecycle and emphasizes conversational access to insights, helping pharma and biotech teams quickly interpret complex datasets. The company’s goal is to accelerate biomarker-driven drug development by delivering a unified data foundation and AI-assisted analysis that speeds decision making across discovery, development, and validation stages.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Frederick, Maryland
Founded
2012
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Life Insurance
Disability Insurance
Parental Leave
Paid Vacation
Paid Sick Leave
Remote Work Options
US-based Precision for Medicine, part of Precision Medicine Group, today announced it is expanding its biomarker data management and translational informatics services into Europe. The addition of a Geneva, Switzerland–based team of experts complements Precision’s US offerings.
FREDERICK, Md. , Jan. 24, 2023 /PRNewswire/ -- Precision for Medicine, the first global, precision medicine clinical research services organization, today announced the strategic acquisition of SolveBio by QuartzBio.
/PRNewswire/ -- Precision for Medicine, the first global, precision medicine clinical research services organization, today announced the strategic acquisition...